JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krantz, J. C.
Right arrow Articles by Knapp, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krantz, J. C., Jr.
Right arrow Articles by Knapp, M. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 102, Issue 4, 258-260, 1951
Copyright © 1951 by American Society for Pharmacology and Experimental Therapeutics


ALKYL NITRITES. XV. THE EFFECT OF NITRITES AND NITRATES ON THE OXYGEN UPTAKE OF ARTERIAL TISSUE

John C. Krantz Jr. 1, C. Jelleff Carr 1, and M. Joyce Knapp 1

1 Department of Pharmacology, School of Medicine, University of Maryland, Baltimore

1. The oxygen uptake of the rat's aorta is inhibited by sodium nitrite in therapeutic concentrations. This does not obtain with sodium nitrate.

2. The vasodilators, erythritol tetranitrate, octyl nitrite and amyl nitrite, do not interfere significantly with the oxygen uptake of arterial tissue in therapeutic levels. Glyceryl trinitrate does inhibit the oxygen uptake of arterial tissue.

3. The relationship between ATPase inhibition, oxygen uptake and vasodilation produced by the drugs of the nitrite-nitrate series is discussed.

Submitted on May 14, 1951







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1951 by the American Society for Pharmacology and Experimental Therapeutics.